GLP-1 Reduces appetite, slows gastric emptying GIP Enhances insulin, improves fat metabolism Glucagon Increases energy expenditure, burns fat Based on Phase 2 clinical trial data (published in NEJM, 2023), retatrutide's side effects are primarily gastrointestinal, similar to other GLP-1 agonists but with some differences due to the glucagon component
This is the same active ingredient in the injectable version of Wegovy and became available for private prescription in June 2026
Regardless of how close or far you are from your goal weight, our skilled and experienced staff will create a customized treatment plan
Se recomienda consumir 3 cpsulas al da con abundante agua o segn indicacin profesional
Don't give up65%+ of appeals succeed with proper documentation
Some researchers find that 8mg provides sufficient results with fewer side effects